Alexandra Mondini, PT, DPT | |
747 Madison Ave Ste 1, Albany, NY 12208-3392 | |
(518) 443-2279 | |
Not Available |
Full Name | Alexandra Mondini |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 747 Madison Ave Ste 1, Albany, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588364855 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 050087 (New York) | Primary |
Provider Name | Access Physical Therapy Wellness Rockland Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1831539493 PECOS PAC ID: 3870735897 Enrollment ID: O20130805000042 |
News Archive
Repligen Corporation today announced preliminary financial results for fiscal year 2010 which ended March 31, 2010. Total revenue for the year is expected to be $21.0 million, including $10.3 million of bioprocessing product revenue and $10.7 million of royalty and other revenue. Research and development expenses are expected to be between $13.8-$14.2 million and selling, general and administrative expenses between $6.8-$7.2 million.
Researchers at National Jewish Health have discovered a signaling pathway that is crucial to the devastating effects of acute lung injury. The data, obtained from cells, animals and ALI patients, suggest several potential therapeutic targets. Experimental blockade of one of the targets significantly reduced flooding of the lungs that is the hallmark of ALI.
Our favourite foods could be made healthier thanks to a new technique developed by the University of Leicester which has identified harmful bacterial molecules in certain processed foods such as burgers and ready meals.
Atopix Therapeutics Limited, a UK biopharmaceutical company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announced that it has raised additional development capital to advance its lead product OC459 for the treatment of asthma.
Marking the conclusion of the three-day Dubai International Humanitarian Aid and Development (DIHAD) conference Tuesday, conference attendees called for humanitarians to adopt a more coordinated approach to tackling global health needs, the National reports. "Speakers, including health professionals and officials from international organisations, stressed the need to share medical knowledge and innovations during a crisis, citing the recent Haiti earthquake," the newspaper writes.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Alexandra Mondini, PT, DPT 16 Maybrook Rd Ste L, Campbell Hall, NY 10916-2741 Ph: (845) 636-4344 | Alexandra Mondini, PT, DPT 747 Madison Ave Ste 1, Albany, NY 12208-3392 Ph: (518) 443-2279 |
News Archive
Repligen Corporation today announced preliminary financial results for fiscal year 2010 which ended March 31, 2010. Total revenue for the year is expected to be $21.0 million, including $10.3 million of bioprocessing product revenue and $10.7 million of royalty and other revenue. Research and development expenses are expected to be between $13.8-$14.2 million and selling, general and administrative expenses between $6.8-$7.2 million.
Researchers at National Jewish Health have discovered a signaling pathway that is crucial to the devastating effects of acute lung injury. The data, obtained from cells, animals and ALI patients, suggest several potential therapeutic targets. Experimental blockade of one of the targets significantly reduced flooding of the lungs that is the hallmark of ALI.
Our favourite foods could be made healthier thanks to a new technique developed by the University of Leicester which has identified harmful bacterial molecules in certain processed foods such as burgers and ready meals.
Atopix Therapeutics Limited, a UK biopharmaceutical company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announced that it has raised additional development capital to advance its lead product OC459 for the treatment of asthma.
Marking the conclusion of the three-day Dubai International Humanitarian Aid and Development (DIHAD) conference Tuesday, conference attendees called for humanitarians to adopt a more coordinated approach to tackling global health needs, the National reports. "Speakers, including health professionals and officials from international organisations, stressed the need to share medical knowledge and innovations during a crisis, citing the recent Haiti earthquake," the newspaper writes.
› Verified 6 days ago
Jordan Iris Bakowski, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 900 Watervliet Shaker Rd, Suite 102, Albany, NY 12205 Phone: 518-862-4900 | |
Yuan Kenneth Jin, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 121 Everett Rd Ste 200, Albany, NY 12205 Phone: 518-489-2524 Fax: 518-489-3167 | |
Penelope M Blasch, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 314 S Manning Blvd, Albany, NY 12208 Phone: 518-453-2273 | |
Heather M. Lacasse, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 121 Everett Rd Health Park, Albany, NY 12205 Phone: 518-489-2524 Fax: 518-489-3167 | |
Marianna Vaysman, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 281 Sand Creek Rd, Albany, NY 12205 Phone: 518-459-1292 Fax: 518-459-1296 | |
Kimberly Silvernail Keane, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 314 S Manning Blvd, Albany, NY 12208 Phone: 518-453-2273 | |
Dr. Janel Lena Carver, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 80 Clinton Ave Apt 1, Albany, NY 12210 Phone: 914-299-9514 |